Barbara Brannetti

Person

Cambridge, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Variant CD58 domains and uses thereof
- Patent number 12,037,378
- Issue date Jul 16, 2024
- Novartis AG
- Barbara Brannetti
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acid molecules encoding chimeric antigen receptors comprisi...
- Patent number RE49847
- Issue date Feb 27, 2024
- Novartis AG
- Barbara Brannetti
Information Patent Grant
Method of treating cancer by administering immune effector cells ex...
- Patent number 11,872,249
- Issue date Jan 16, 2024
- Novartis AG
- Barbara Brannetti
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method of detecting TIM-3 using antibody molecules to TIM-3
- Patent number 11,155,620
- Issue date Oct 26, 2021
- Novartis AG
- Catherine Anne Sabatos-Peyton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CD20 therapies, CD22 therapies, and combination therapies with a CD...
- Patent number 11,149,076
- Issue date Oct 19, 2021
- Novartis AG
- Hans Bitter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IL-18 binding molecules
- Patent number 11,111,293
- Issue date Sep 7, 2021
- Novartis AG
- Michael Otto Bardroff
- G01 - MEASURING TESTING
Information Patent Grant
Nucleic acid molecules encoding chimeric antigen receptors comprisi...
- Patent number 11,026,976
- Issue date Jun 8, 2021
- Novartis AG
- Barbara Brannetti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody molecules to TIM-3 and uses thereof
- Patent number 10,981,990
- Issue date Apr 20, 2021
- Novartis AG
- Catherine Anne Sabatos-Peyton
- G01 - MEASURING TESTING
Information Patent Grant
Nucleic acids encoding anti-Factor P antibodies
- Patent number 10,865,237
- Issue date Dec 15, 2020
- Novartis AG
- Leslie Ngozi Anuna Johnson
- G01 - MEASURING TESTING
Information Patent Grant
Nucleic acid molecules encoding chimeric antigen receptors comprisi...
- Patent number 10,525,083
- Issue date Jan 7, 2020
- Novartis AG
- Barbara Brannetti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
TREATMENT OF CANCER USING CHIMERIC ANTIGEN RECEPTORS
- Publication number 20240252538
- Publication date Aug 1, 2024
- Novartis AG
- Barbara Brannetti
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...
- Publication number 20230374105
- Publication date Nov 23, 2023
- Novartis AG
- Hans Bitter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VARIANT CD58 DOMAINS AND USES THEREOF
- Publication number 20230071196
- Publication date Mar 9, 2023
- Novartis AG
- Barbara BRANNETTI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NUCLEIC ACID MOLECULES ENCODING CHIMERIC ANTIGEN RECEPTORS COMPRISI...
- Publication number 20220387486
- Publication date Dec 8, 2022
- Novartis AG
- Barbara Brannetti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...
- Publication number 20220195010
- Publication date Jun 23, 2022
- Novartis AG
- Hans Bitter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD OF DETECTING TIM-3 USING ANTIBODY MOLECULES TO TIM-3
- Publication number 20220185883
- Publication date Jun 16, 2022
- Novartis AG
- Catherine Anne Sabatos-Peyton
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3
- Publication number 20220133889
- Publication date May 5, 2022
- Novartis AG
- Glenn Dranoff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-18 BINDING MOLECULES
- Publication number 20220098296
- Publication date Mar 31, 2022
- Novartis AG
- Michael Otto Bardroff
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF
- Publication number 20200308277
- Publication date Oct 1, 2020
- Novartis AG
- Catherine Anne Sabatos-Peyton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF
- Publication number 20200223917
- Publication date Jul 16, 2020
- Novartis AG
- Catherine Anne Sabatos-Peyton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NUCLEIC ACID MOLECULES ENCODING CHIMERIC ANTIGEN RECEPTORS COMPRISI...
- Publication number 20200113941
- Publication date Apr 16, 2020
- Novartis AG
- Barbara Brannetti
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...
- Publication number 20190292238
- Publication date Sep 26, 2019
- Novartis AG
- Hans Bitter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-18 BINDING MOLECULES
- Publication number 20190085068
- Publication date Mar 21, 2019
- Novartis AG
- Michael Otto Bardroff
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING FACTOR P
- Publication number 20180327486
- Publication date Nov 15, 2018
- Novartis AG
- Leslie Ngozi Anuna JOHNSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING CHIMERIC ANTIGEN RECEPTORS
- Publication number 20180125892
- Publication date May 10, 2018
- Barbara Brannetti
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Barbara Brannetti

Person

Patents Grantslast 30 patents

Variant CD58 domains and uses thereof

Nucleic acid molecules encoding chimeric antigen receptors comprisi...

Method of treating cancer by administering immune effector cells ex...

Method of detecting TIM-3 using antibody molecules to TIM-3

CD20 therapies, CD22 therapies, and combination therapies with a CD...

IL-18 binding molecules

Nucleic acid molecules encoding chimeric antigen receptors comprisi...

Antibody molecules to TIM-3 and uses thereof

Nucleic acids encoding anti-Factor P antibodies

Nucleic acid molecules encoding chimeric antigen receptors comprisi...

Patents Applicationslast 30 patents

TREATMENT OF CANCER USING CHIMERIC ANTIGEN RECEPTORS

CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...

VARIANT CD58 DOMAINS AND USES THEREOF

NUCLEIC ACID MOLECULES ENCODING CHIMERIC ANTIGEN RECEPTORS COMPRISI...

CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...

METHOD OF DETECTING TIM-3 USING ANTIBODY MOLECULES TO TIM-3

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3

IL-18 BINDING MOLECULES

ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF

ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF

NUCLEIC ACID MOLECULES ENCODING CHIMERIC ANTIGEN RECEPTORS COMPRISI...

CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...

IL-18 BINDING MOLECULES

COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING FACTOR P

TREATMENT OF CANCER USING CHIMERIC ANTIGEN RECEPTORS